Histopathologically, Appay et al. showed that among IDH-mutant gliomas, the presence of CDKN2A deletion was associated with a higher mitotic count and Ki67 labeling index than in those without CDKN2A deletion [12]. This evidence concerns the gene MKI67 and central nervous system cancer.